Swiss drugmaker Roche, frustrated by stalled negotiations to purchase Bay Area biotech giant Genentech Inc., announced a hostile $42.1 billion takeover bid Friday that would net investors less than the $89 per share offer that Genentech rejected in August….

Email this Article
Add to del.icio.us
Add to digg
Add to Facebook


See the original post here:
Roche tries hostile takeover bid for Genentech